Shilpa Medicare Unit VI facility at Dabaspet receives GMP certification from SFDA
This was a full GMP inspection of the entire facility with specific focus on Ondansetron Oral Film drug product
This was a full GMP inspection of the entire facility with specific focus on Ondansetron Oral Film drug product
The company has confirmed that the deceased are 39
The company will provide the necessary response to USFDA within stipulated 15 days
The inspection concluded successfully, with the facility found to be in compliance with the required regulations
The project will be instrumental in enhancing the company's API manufacturing capacity and global reach
Zydus receives EIR for the API manufacturing facility at Ankleshwar
Facility also named 2025 ISPE Facility of the Year Winner for Social Impact - Unmet Medical Needs
The inspection conducted from December 16, 2024 to December 20, 2024 by the Brazil Health Regulatory Agency (ANVISA)
These observations are procedural in nature and none of them are related to data integrity
Subscribe To Our Newsletter & Stay Updated